Market Tracker

07/21 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

20.65
Delayed Data
As of Jul 21
 -0.25 / -1.20%
Today’s Change
13.60
Today|||52-Week Range
33.00
+9.84%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close20.90
Today’s open21.00
Day’s range20.40 - 21.50
Volume1,012,995
Average volume (3 months)1,022,089
Market cap$963.5M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+688.57%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.12+0.55%
ADROAduro Biotech Inc+0.05+0.36%
SGYPSynergy Pharmaceutic...-0.01-0.23%
CLLSCellectis SA+0.04+0.15%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts